These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 12145368)
61. Use of Hormone Replacement Therapy and Risk of Dementia: A Nationwide Cohort Study. Sung YF; Tsai CT; Kuo CY; Lee JT; Chou CH; Chen YC; Chou YC; Sun CA Neurology; 2022 Oct; 99(17):e1835-e1842. PubMed ID: 36240091 [TBL] [Abstract][Full Text] [Related]
62. The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment. Hajjar I; Schumpert J; Hirth V; Wieland D; Eleazer GP J Gerontol A Biol Sci Med Sci; 2002 Jul; 57(7):M414-8. PubMed ID: 12084801 [TBL] [Abstract][Full Text] [Related]
63. Hormone replacement therapy: patterns of use studied through British general practice computerized records. Lawrence M; Jones L; Lancaster T; Daly E; Banks E Fam Pract; 1999 Aug; 16(4):335-42. PubMed ID: 10493702 [TBL] [Abstract][Full Text] [Related]
64. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. Espeland MA; Rapp SR; Shumaker SA; Brunner R; Manson JE; Sherwin BB; Hsia J; Margolis KL; Hogan PE; Wallace R; Dailey M; Freeman R; Hays J; JAMA; 2004 Jun; 291(24):2959-68. PubMed ID: 15213207 [TBL] [Abstract][Full Text] [Related]
65. Detection and management of cognitive impairment in primary care: The Steel Valley Seniors Survey. Ganguli M; Rodriguez E; Mulsant B; Richards S; Pandav R; Bilt JV; Dodge HH; Stoehr GP; Saxton J; Morycz RK; Rubin RT; Farkas B; DeKosky ST J Am Geriatr Soc; 2004 Oct; 52(10):1668-75. PubMed ID: 15450043 [TBL] [Abstract][Full Text] [Related]
67. Hormone replacement therapy, body mass, and the risk of colorectal cancer among postmenopausal women from Germany. Hoffmeister M; Raum E; Winter J; Chang-Claude J; Brenner H Br J Cancer; 2007 Dec; 97(11):1486-92. PubMed ID: 17987040 [TBL] [Abstract][Full Text] [Related]
68. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group. Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251 [TBL] [Abstract][Full Text] [Related]
69. Description of women's personality traits and psychological vulnerability prior to choosing hormone replacement therapy. Loekkegaard E; Eplov LF; Køster A; Garde K Arch Womens Ment Health; 2002 Aug; 5(1):23-31. PubMed ID: 12503071 [TBL] [Abstract][Full Text] [Related]
70. Hormone Replacement Therapy and Development of New Asthma. Hansen ESH; Aasbjerg K; Moeller AL; Gade EJ; Torp-Pedersen C; Backer V Chest; 2021 Jul; 160(1):45-52. PubMed ID: 33775661 [TBL] [Abstract][Full Text] [Related]
71. Socioeconomic status and use of postmenopausal hormone replacement therapy among Danish women. Olesen AV; Johnsen SP; Mortensen JT; Bøggild H; Olsen J; Sørensen HT Acta Obstet Gynecol Scand; 2005 Jul; 84(7):639-44. PubMed ID: 15954872 [TBL] [Abstract][Full Text] [Related]
72. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women. Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517 [TBL] [Abstract][Full Text] [Related]
73. Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study. Varas-Lorenzo C; García-Rodríguez LA; Perez-Gutthann S; Duque-Oliart A Circulation; 2000 Jun; 101(22):2572-8. PubMed ID: 10840007 [TBL] [Abstract][Full Text] [Related]
74. Effect of age on reasons for initiation and discontinuation of hormone replacement therapy. Ettinger B; Pressman A; Silver P Menopause; 1999; 6(4):282-9. PubMed ID: 10614674 [TBL] [Abstract][Full Text] [Related]
75. Issues concerning the use of hormone replacement therapy and risk of fracture: a population-based, nested case-control study. Corrao G; Zambon A; Nicotra F; Conti V; Nappi RE; Merlino L Br J Clin Pharmacol; 2008 Jan; 65(1):123-9. PubMed ID: 17953723 [TBL] [Abstract][Full Text] [Related]
76. Concomitant medication use in postmenopausal women using estrogen therapy. Small R; Friedman GD; Ettinger B Menopause; 2001; 8(2):120-6. PubMed ID: 11256872 [TBL] [Abstract][Full Text] [Related]
77. The effect of hormone replacement therapy on the survival of UK women: a retrospective cohort study 1984-2017. Akter N; Kulinskaya E; Steel N; Bakbergenuly I BJOG; 2022 May; 129(6):994-1003. PubMed ID: 34773357 [TBL] [Abstract][Full Text] [Related]
79. Relationships Between Caffeine Intake and Risk for Probable Dementia or Global Cognitive Impairment: The Women's Health Initiative Memory Study. Driscoll I; Shumaker SA; Snively BM; Margolis KL; Manson JE; Vitolins MZ; Rossom RC; Espeland MA J Gerontol A Biol Sci Med Sci; 2016 Dec; 71(12):1596-1602. PubMed ID: 27678290 [TBL] [Abstract][Full Text] [Related]
80. Timing of hormone therapy and dementia: the critical window theory revisited. Whitmer RA; Quesenberry CP; Zhou J; Yaffe K Ann Neurol; 2011 Jan; 69(1):163-9. PubMed ID: 21280086 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]